Curematch
CureMatch, Inc. is a San Diego-based digital health company specializing in precision oncology through personalized medicine and combination therapy. Their Decision Support System uses advanced proprietary algorithms and extensive genomic, proteomic, and clinical data curation to provide oncologists with ranked, customized combination cancer drug treatment options tailored to individual patients' molecular tumor profiles. CureMatch's technology enables oncologists to make actionable, predictive treatment decisions, improving progression-free survival in 75% of patients treated with their recommended combination therapies. The company has achieved significant traction with partnerships across cancer centers, NGS labs, and concierge medicine providers, and has been granted a Category III CPT code (0794T) by the American Medical Association to facilitate reimbursement for their therapy matching service. CureMatch leverages AI, Knowledge Representation & Reasoning (KRR), and targeted proteomics to maintain a leading position in precision oncology treatment support.
Curematch
CureMatch, Inc. is a San Diego-based digital health company specializing in precision oncology through personalized medicine and combination therapy. Their Decision Support System uses advanced proprietary algorithms and extensive genomic, proteomic, and clinical data curation to provide oncologists with ranked, customized combination cancer drug treatment options tailored to individual patients' molecular tumor profiles. CureMatch's technology enables oncologists to make actionable, predictive treatment decisions, improving progression-free survival in 75% of patients treated with their recommended combination therapies. The company has achieved significant traction with partnerships across cancer centers, NGS labs, and concierge medicine providers, and has been granted a Category III CPT code (0794T) by the American Medical Association to facilitate reimbursement for their therapy matching service. CureMatch leverages AI, Knowledge Representation & Reasoning (KRR), and targeted proteomics to maintain a leading position in precision oncology treatment support.